How do we take CRISPR from the lab to the clinic?

Advances in use of the CRISPR genome editing technology have been arriving at breakneck speed. But even as the first clinical trials of the technique are expected to start before the end of the year, scientists have found that CRISPR might in some circumstances pose unexpected risks to patients. We invite you to join Senior Science Writer Sharon Begley at HUBweek in Boston, as she leads a panel discussion exploring the challenges of turning a revolutionary lab technique into a therapy. Reserve your seat today for the Oct. 9 event. (Coffee and snacks will be provided.)